-
Taiwan's new opposition leader against defence spending hike
-
China to exempt some Nexperia chips from export ban
-
Dodgers hold off Blue Jays 3-1 to force World Series game seven
-
Crowns, beauty, fried chicken: Korean culture meets diplomacy at APEC
-
Panama wins canal expansion arbitration against Spanish company
-
Myanmar fireworks festival goers shun politics for tradition
-
China to exempt some Nexperia orders from export ban
-
Sixers suffer first loss as NBA Cup begins
-
China's Xi to meet South Korean leader, capping APEC summit
-
Japan's Chiba leads after Skate Canada short program
-
Finland's crackdown on undocumented migrants sparks fear
-
Climbers test limits at Yosemite, short-staffed by US shutdown
-
Gstaad gives O'Brien record 21st Breeders' Cup win
-
After the tears, anger on Rio's blood-stained streets
-
Sinner boosts number one bid in Paris, to face Zverev in semis
-
Springer back in Toronto lineup as Blue Jays try to close out Dodgers
-
Nationals make Butera MLB's youngest manager since 1972
-
Guirassy lifts Dortmund past Augsburg ahead of Man City clash
-
G7 says it's 'serious' about confronting China's critical mineral dominance
-
NFL fines Ravens $100,000 over Jackson injury status report
-
NBA refs to start using headsets on Saturday
-
Trump says Christians in Nigeria face 'existential threat'
-
French-Turkish actor Tcheky Karyo dies at 72
-
Food stamps, the bulwark against hunger for over 40 mn Americans
-
Trump keeps world guessing with shock nuclear test order
-
Wall Street stocks rebound on Amazon, Apple earnings
-
US Fed official backed rate pause because inflation 'too high'
-
Prayers and anthems: welcome to the Trump-era Kennedy Center
-
Swiss central bank profits boosted by gold price surge
-
Sinner beats Shelton to boost number one bid in Paris
-
French court jails Bulgarians for up to four years for Holocaust memorial defacement
-
Profits dip at ExxonMobil, Chevron on lower crude prices
-
Ashraf and Mirza skittle South Africa as Pakistan win 2nd T20
-
2,000 trucks stuck in Belarus after Lithuania closes border: association
-
French lawmakers reject wealth tax proposal in budget debate
-
Premier League blames European expansion for lack of Boxing Day games
-
Bublik sets up Auger-Aliassime semi-final at Paris Masters
-
World's most expensive coffee goes on sale in Dubai at $1,000 a cup
-
Trump stirs global tensions, confusion with nuclear test order
-
Panic across US as health insurance costs set to surge
-
Court eases ban on Russian lugers but Olympic hopes on thin ice
-
England captain Itoje targets Autumn Nations clean sweep
-
Calmer Sabalenka sets sights on WTA Finals crown
-
Spurs boosted by Romero return for Chelsea clash
-
Sudan's RSF claims arrests as UN warns of 'horrendous' atrocities in Darfur
-
US says 'non-market' tactics needed to counter China's rare earth dominance
-
China sends youngest astronaut, mice to space station
-
From adored prince to outcast, Andrew's years-long fall from grace
-
Rodri return fuels Guardiola belief in Man City title challenge
-
China holds send-off ceremony for space station astronauts
RFK Jr panel votes against ingredient targeted by anti-vaxxers
A newly appointed US medical panel voted Thursday to oppose the use of a vaccine ingredient long targeted by Health Secretary Robert F. Kennedy Jr. over debunked claims it causes autism.
Thimerosal, a preservative that prevents bacterial and fungal contamination in multidose vials, has been extensively studied, with authorities including the World Health Organization finding no evidence of harm beyond minor injection-site reactions.
Though thimerosal is now rarely used in US vaccines, its inclusion on the Advisory Committee on Immunization Practices' agenda alarmed experts, who say the move has effectively embedded anti-vaccine talking points into national policy.
Kennedy -- who spent decades spreading vaccine misinformation before becoming President Donald Trump's top health official -- abruptly fired all 17 ACIP members earlier this month, accusing them of conflicts of interest.
Across three votes, his new handpicked panelists recommended that thimerosal be removed from influenza vaccines for children, pregnant women and finally all adults.
Cody Meissner, a professor of pediatrics at Dartmouth University and the lone voice of dissent, said: "The risk from influenza is so much greater than the nonexistent risk as far as we know from thimerosal," adding that he was worried about the decision's global impact.
Although 96 percent of US flu vaccines in the 2024-2025 season did not contain thimerosal, the preservative remains important globally, particularly in multidose vials that must be punctured repeatedly, raising the risk of contamination.
Thimerosal contains an artificial form of mercury called ethylmercury that is cleared from the body far more quickly than the form of the substance found in nature.
US manufacturers voluntarily removed it from most pediatric vaccines in 2001.
- 'Platform for anti-vaccine talking points' -
"The fact that it's being brought up again -- something that's already been adjudicated -- shows how the ACIP is becoming a platform for anti-vaccine talking points to come back to life long after most of us thought they'd been put to rest," Amesh Adalja, an infectious disease specialist at Johns Hopkins University, told AFP.
Ahead of the vote, Lyn Redwood, a nurse and former leader of the anti-vaccine group Children's Health Defense, which Kennedy once chaired, was invited to present arguments against thimerosal.
A previous version of her slideshow, which was posted online before the meeting, was removed without explanation after it was found to contain a fabricated citation, likely the result of an AI hallucination.
The Centers for Disease Control and Prevention had prepared a rebuttal to Redwood's presentation, but it was mysteriously removed from the meeting website.
Robert Malone, a new panel member known for spreading misinformation during the Covid-19 pandemic, including promoting the antiparastic drug ivermectin to treat the virus, later said the CDC document had not been approved by the Office of the Secretary.
Earlier in the meeting, the same panel voted to recommend a new antibody treatment against RSV, a common respiratory illness and the leading cause of infant hospitalization in the United States.
Clesrovimab, recently approved by the Food and Drug Administration, is administered as a single shot to newborns and young babies entering their first respiratory syncytial virus season.
Marketed as Enflonsia by Merck, it was shown in clinical trials to significantly reduce RSV infections and hospitalizations among infants.
O.Mousa--SF-PST